This comprehensive and independent report sets a clear roadmap for how digital inclusion can improve the health and well-being of many people in Wales.
This report argues that leveraging new technologies will be instrumental in improving healthcare access and affordability for taxpayers.
This joint report from the Carnegie UK Trust and Wales Cooperative Centre examines the potential for digital inclusion to improve the health and wellbeing of older people in Wales with a limiting long-term condition.
This article summarises a new framework to improve the success of technology projects: the nonadoption, abandonment, scaleup, spread and sustainability (NASSS) framework.
This resource aims to shine a light on how qualitative methods are being used in health services and medical research contexts, and how they might be used more effectively.
This report sets out why and how the United Kingdom needs to escape the biomedical bubble if it is to realise the economic, social and health potential of new investment in research and development.
This report looks at the science of mitochondrial donation and evaluates whether the Australian government should consider making mitochondrial donation available within Australia, and if so, under what kind of regulatory regime.
Over the past few years, a number of Australians have expressed interest in the use of cannabis for medicinal purposes. There have only been a limited number of well-designed clinical studies on medicinal cannabis and so it is hard for some doctors to find quality...
In rural Australia, knowledge and utilisation of support by informal carers is lacking. Developing and improving access to peer support to enable carers to effectively cope with the challenges of caring may positively influence their caring experience.
This report analysed 25 Australian clinical trials initiated by clinicians and found that if the results of the trials were implemented in just two-thirds of the relevant groups of patients for one year, $1.4 billion would be saved through improvements in patient health outcomes, and...
There is a lot of economic opportunity for Victorian companies to develop and manufacture new drugs, devices and digital health solutions that will shape the future of healthcare.
Victoria's first legal crop of cannabis has just been harvested for medicinal use.
The state has been manufacturing the drug at a secret location and is still putting it through the testing phase.
While patients in Victoria wait for access, NSW parliamentarians have...
The Policy Project collaborated with the Government Economics Network (GEN) committee to facilitate workshops following the 2016 GEN conference on ‘People and Policy – how to make better and smarter policies through behavioural insights, design thinking and better use of data’.
This document records:...
How should Australia take advantage of the opportunities that new technologies offer to improve health and care? Many people want to be more informed and involved with their own care and learn how to prevent illness and improve wellbeing. Clinicians and carers want to be...
Health Innovation Communities (HICs) would essentially constitute an Australian ‘Silicon Valley’ for health – hubs for research and development within which the proverbial 1000 flowers will bloom as a plurality of different providers create novel health products and solutions. The good examples and real world...
The Victorian government says it's on track to treat child sufferers of epilepsy with medicinal cannabis by next year. Several other states are conducting similar trials, but only the Victorians are cultivating their own product.
Victoria’s Health and Medical Research Strategy 2016–2020 (the strategy) is designed to embed health and medical research into the Victorian health system and accelerate the translation of research into clinical practice. The vision of this strategy is to position Victoria as a global leader in...
The best use of diagnostic imaging is a challenge for many health professionals and the health system. Potential hazards of inappropriate imaging include exposure to ionising radiation, false positive and negative results, unexpected incidental findings, overdiagnosis and cost.
While normal imaging results can reassure...